Molbio Diagnostics Soars 21% in Impressive Market Launch
Molbio Diagnostics debuted at a 21.44% premium, opening at Rs 980 against an IPO price of Rs 807.
Read moreDetailsADVERTISEMENT
Tag: Molbio Diagnostic
LEAP India and Molbio Diagnostics Gain SEBI Approval for Initial Public Offerings
LEAP India and Molbio Diagnostics have received SEBI approval for their initial public offerings.
Read moreDetailsMolbio Diagnostics Achieves ₹1,020 Crore in Revenue with a ₹138 Crore Profit in FY25
Goa-based Molbio closed FY25 with Rs 1,020 crore revenue and Rs 138.5 crore profit, marking a sharp recovery.
Read moreDetails